vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $58.6M, roughly 1.3× Vitesse Energy, Inc.). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -39.1%, a 37.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs 4.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs -2.1%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.

PRCT vs VTS — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$76.4M
$58.6M
VTS
Growing faster (revenue YoY)
PRCT
PRCT
+7.1% gap
PRCT
11.9%
4.8%
VTS
Higher net margin
VTS
VTS
37.8% more per $
VTS
-1.3%
-39.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
-2.1%
VTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRCT
PRCT
VTS
VTS
Revenue
$76.4M
$58.6M
Net Profit
$-29.8M
$-739.0K
Gross Margin
60.6%
Operating Margin
-40.6%
-12.0%
Net Margin
-39.1%
-1.3%
Revenue YoY
11.9%
4.8%
Net Profit YoY
-58.3%
85.6%
EPS (diluted)
$-0.54
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
VTS
VTS
Q4 25
$76.4M
$58.6M
Q3 25
$83.3M
$67.4M
Q2 25
$79.2M
$81.8M
Q1 25
$69.2M
$66.2M
Q4 24
$68.2M
$55.9M
Q3 24
$58.4M
$58.3M
Q2 24
$53.4M
$66.6M
Q1 24
$44.5M
$61.2M
Net Profit
PRCT
PRCT
VTS
VTS
Q4 25
$-29.8M
$-739.0K
Q3 25
$-21.4M
$-1.3M
Q2 25
$-19.6M
$24.7M
Q1 25
$-24.7M
$2.7M
Q4 24
$-18.9M
$-5.1M
Q3 24
$-21.0M
$17.4M
Q2 24
$-25.6M
$10.9M
Q1 24
$-26.0M
$-2.2M
Gross Margin
PRCT
PRCT
VTS
VTS
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Q1 24
56.2%
Operating Margin
PRCT
PRCT
VTS
VTS
Q4 25
-40.6%
-12.0%
Q3 25
-27.8%
0.2%
Q2 25
-28.0%
22.8%
Q1 25
-39.7%
8.1%
Q4 24
-28.9%
3.7%
Q3 24
-38.4%
15.4%
Q2 24
-50.3%
25.2%
Q1 24
-62.1%
21.4%
Net Margin
PRCT
PRCT
VTS
VTS
Q4 25
-39.1%
-1.3%
Q3 25
-25.7%
-1.9%
Q2 25
-24.7%
30.2%
Q1 25
-35.8%
4.0%
Q4 24
-27.6%
-9.2%
Q3 24
-35.9%
29.9%
Q2 24
-48.0%
16.4%
Q1 24
-58.3%
-3.6%
EPS (diluted)
PRCT
PRCT
VTS
VTS
Q4 25
$-0.54
$-0.01
Q3 25
$-0.38
$-0.03
Q2 25
$-0.35
$0.60
Q1 25
$-0.45
$0.08
Q4 24
$-0.34
$-0.15
Q3 24
$-0.40
$0.53
Q2 24
$-0.50
$0.33
Q1 24
$-0.51
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
VTS
VTS
Cash + ST InvestmentsLiquidity on hand
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$365.9M
$629.3M
Total Assets
$508.1M
$893.4M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
VTS
VTS
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
$4.5M
Q4 24
$333.7M
$3.0M
Q3 24
$196.8M
Q2 24
$214.1M
Q1 24
$225.6M
Total Debt
PRCT
PRCT
VTS
VTS
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
PRCT
PRCT
VTS
VTS
Q4 25
$365.9M
$629.3M
Q3 25
$380.3M
$650.3M
Q2 25
$385.8M
$671.9M
Q1 25
$389.2M
$667.7M
Q4 24
$402.2M
$500.3M
Q3 24
$241.2M
$520.4M
Q2 24
$251.8M
$518.5M
Q1 24
$264.0M
$522.7M
Total Assets
PRCT
PRCT
VTS
VTS
Q4 25
$508.1M
$893.4M
Q3 25
$511.5M
$932.9M
Q2 25
$513.1M
$951.5M
Q1 25
$519.4M
$975.2M
Q4 24
$534.0M
$810.9M
Q3 24
$374.1M
$791.2M
Q2 24
$374.4M
$778.4M
Q1 24
$382.9M
$749.7M
Debt / Equity
PRCT
PRCT
VTS
VTS
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
VTS
VTS
Operating Cash FlowLast quarter
$-10.3M
$37.4M
Free Cash FlowOCF − Capex
$-12.2M
FCF MarginFCF / Revenue
-15.9%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
VTS
VTS
Q4 25
$-10.3M
$37.4M
Q3 25
$-6.6M
$49.4M
Q2 25
$-15.0M
$66.0M
Q1 25
$-17.0M
$17.5M
Q4 24
$-32.4M
$34.7M
Q3 24
$-18.8M
$45.7M
Q2 24
$-15.7M
$35.2M
Q1 24
$-32.3M
$39.4M
Free Cash Flow
PRCT
PRCT
VTS
VTS
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
Q1 24
$-34.2M
FCF Margin
PRCT
PRCT
VTS
VTS
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Q1 24
-76.9%
Capex Intensity
PRCT
PRCT
VTS
VTS
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Q1 24
4.4%
Cash Conversion
PRCT
PRCT
VTS
VTS
Q4 25
Q3 25
Q2 25
2.68×
Q1 25
6.56×
Q4 24
Q3 24
2.62×
Q2 24
3.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

VTS
VTS

Oil Reserves$54.5M93%
Natural Gas Reserves$4.2M7%

Related Comparisons